Regencell Bioscience
RGC
$4.08
Share price
-6.20%
Change (1 day)
-82.94%
Change (1 year)
Categories
Regencell Bioscience (RGC) - P/B ratio
P/B ratio as of June 2024 : 5.21
According to Regencell Bioscience's latest financial reports the company has a price-to-book ratio of 5.21.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Regencell Bioscience - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 11.4 | -53.92% |
| 2022-12-31 | 24.7 | 17.97% |
| 2021-12-31 | 21.0 | |
| 2020-12-31 | N/A |